Mendus AB (publ) - Asset Resilience Ratio

Latest as of December 2025: 10.29%

Mendus AB (publ) (IMMU) has an Asset Resilience Ratio of 10.29% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See IMMU working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Skr64.66 Million

≈ $6.96 Million USD Cash + Short-term Investments

Total Assets

Skr628.32 Million

≈ $67.62 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2025)

This chart shows how Mendus AB (publ)'s Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see total assets of Mendus AB (publ).

Liquid Assets Composition Over Time

This chart breaks down Mendus AB (publ)'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore IMMU long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr64.66 Million	10.29%
Short-term Investments	Skr0.00	0%
Total Liquid Assets	Skr64.66 Million	10.29%

Asset Resilience Insights

Moderate Liquidity: Mendus AB (publ) has 10.29% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Mendus AB (publ) Industry Peers by Asset Resilience Ratio

Compare Mendus AB (publ)'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tubize-Fin BR:TUB	Biotechnology	2.50%
Dianthus Therapeutics Inc. NASDAQ:DNTH	Biotechnology	63.98%
Tango Therapeutics Inc NASDAQ:TNGX	Biotechnology	62.24%
Damora Therapeutics, Inc. NASDAQ:DMRA	Biotechnology	0.00%
Wecome Pharmaceutical Co Ltd SHE:300878	Biotechnology	0.67%
Tectonic Therapeutic, Inc. NASDAQ:TECX	Biotechnology	86.66%
Relmada Therapeutics Inc NASDAQ:RLMD	Biotechnology	95.25%
MediWound Ltd F:M8W	Biotechnology	56.04%

Annual Asset Resilience Ratio for Mendus AB (publ) (2014–2025)

The table below shows the annual Asset Resilience Ratio data for Mendus AB (publ).

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	10.29%	Skr64.66 Million ≈ $6.96 Million	Skr628.32 Million ≈ $67.62 Million	-4.34pp
2024-12-31	14.63%	Skr101.91 Million ≈ $10.97 Million	Skr696.36 Million ≈ $74.94 Million	-1.34pp
2023-12-31	15.98%	Skr120.78 Million ≈ $13.00 Million	Skr755.95 Million ≈ $81.35 Million	+9.23pp
2022-12-31	6.75%	Skr41.85 Million ≈ $4.50 Million	Skr620.39 Million ≈ $66.76 Million	-14.80pp
2021-12-31	21.54%	Skr155.31 Million ≈ $16.71 Million	Skr720.98 Million ≈ $77.59 Million	-1.47pp
2020-12-31	23.01%	Skr167.64 Million ≈ $18.04 Million	Skr728.66 Million ≈ $78.42 Million	+18.53pp
2019-12-31	4.47%	Skr13.59 Million ≈ $1.46 Million	Skr303.83 Million ≈ $32.70 Million	-94.27pp
2018-12-31	98.74%	Skr444.70 Million ≈ $47.86 Million	Skr450.37 Million ≈ $48.47 Million	+46.61pp
2017-12-31	52.13%	Skr128.32 Million ≈ $13.81 Million	Skr246.15 Million ≈ $26.49 Million	+44.29pp
2016-12-31	7.84%	Skr9.53 Million ≈ $1.03 Million	Skr121.57 Million ≈ $13.08 Million	+1.68pp
2015-12-31	6.15%	Skr9.49 Million ≈ $1.02 Million	Skr154.24 Million ≈ $16.60 Million	-43.72pp
2014-12-31	49.87%	Skr35.43 Million ≈ $3.81 Million	Skr71.03 Million ≈ $7.64 Million	--

pp = percentage points

About Mendus AB (publ)

ST:IMMU Sweden Biotechnology

Market Cap

$42.60 Million

Skr395.89 Million SEK

Market Cap Rank

#22577 Global

#423 in Sweden

Share Price

Skr6.46

Change (1 day)

+1.89%

52-Week Range

Skr3.96 - Skr7.47

All Time High

Skr737.49